http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102120760-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4c7912a78b3e3e005956d35959b0374 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2010-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0317ab097251adc438bd9ec44dc9532c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60c0847aca58ebdda181e74be0ec7535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ef32ed059b0c25da746d34a25f8d349 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ecd339a10335b88322e9c6b8a0d35e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24c39a4e6199cf66905c4bcc7166af91 |
| publicationDate | 2013-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102120760-B |
| titleOfInvention | Antibacterial peptide derived from phage and application thereof |
| abstract | The invention discloses an antibacterial peptide derived from a phage and application thereof in preparing a bacteriostat. The antibacterial peptide has total or partial amino acid sequences shown in SEQ ID No:1 in the specification; sequence structure analysis and sequence comparison analysis show that the protease is an endolysin in a phage; and experiments demonstrate that protein formed by the total or partial amino acid sequences (such as 1-87aa, 34-157aa or 110-157aa) of the sequence has better bactericidal activity. The invention has the main beneficial effects that the antibacterial peptide has the advantages of high efficiency, low toxicity and wide application range, can be used for preparing the bacteriostat, and has an obvious bactericidal effect on a series of pathogenic bacteria in vitro after being expressed and purified by traditional proper expression carriers in the market. |
| priorityDate | 2010-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 187.